US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist
  • 19.830
  • +0.460+2.37%
Close Nov 27 16:00 ET
  • 19.830
  • 0.0000.00%
Post 16:03 ET
742.04MMarket Cap13.77P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
249.07%139.8M
85.30%-4.01M
10.88%-24.49M
-94.85%-35.09M
1,068.98%203.4M
-84.39%-93.79M
-32.92%-27.3M
Net income from continuing operations
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
Depreciation and amortization
12.35%937K
24.66%910K
72.64%934K
49.92%2.84M
39.92%736K
61.63%834K
57.67%730K
38.72%541K
69.65%1.9M
44.51%526K
Change In working capital
79.44%-12.82M
-63.14%-18.47M
-124.95%-51.65M
1,326.85%136.32M
149.39%2.95M
-1,025.92%-62.33M
-652.24%-11.32M
12,676.79%207.01M
-224.79%-11.11M
-55.82%-5.98M
-Change in receivables
495.86%5.07M
2,635.61%69.84M
-1,037.62%-71.64M
---5.88M
---853K
---1.28M
--2.55M
---6.3M
--0
--0
-Change in prepaid assets
91.39%-1.27M
-143.88%-2.87M
-38.23%2.68M
161.49%8.62M
725.17%12.52M
-55.36%-14.78M
881.03%6.55M
359.82%4.34M
-108.26%-14.02M
68.14%-2M
-Change in payables and accrued expense
114.60%865K
51.04%-1.01M
-129.00%-1.35M
-28.63%5.03M
3,240.64%8.39M
-248.21%-5.92M
-191.39%-2.07M
767.48%4.64M
117.09%7.05M
-68.55%251K
-Change in other current assets
43.47%2.61M
59.77%4.59M
148.29%2.56M
-87.14%426K
146.70%1.03M
-6.23%1.82M
11.97%2.87M
-619.71%-5.3M
1,100.91%3.31M
-239.07%-2.21M
-Change in other current liabilities
20.98%-3.13M
70.72%-1.99M
7.79%-1.8M
-59.20%-11.86M
141.76%841K
-101.63%-3.96M
-249.79%-6.79M
-27.37%-1.95M
---7.45M
---2.01M
-Change in other working capital
55.60%-16.97M
-503.22%-87.02M
-91.54%17.9M
--139.98M
---18.97M
---38.21M
---14.43M
--211.58M
----
----
Cash from discontinued investing activities
Operating cash flow
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
249.07%139.8M
85.30%-4.01M
10.88%-24.49M
-94.85%-35.09M
1,068.98%203.4M
-84.39%-93.79M
-32.92%-27.3M
Investing cash flow
Cash flow from continuing investing activities
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
6.90%-138.4M
1.34%19.04M
63.12%-3.74M
-567.52%-113.26M
77.72%-40.44M
-3,145.63%-148.65M
1,521.48%18.79M
Net PPE purchase and sale
55.87%-639K
31.27%-1.05M
49.76%-838K
-94.46%-5.61M
-37.85%-976K
-78.77%-1.45M
-96.39%-1.52M
-180.81%-1.67M
36.97%-2.89M
46.44%-708K
Net investment purchase and sale
-3,494.93%-82.29M
79.11%-23.34M
169.59%26.99M
8.91%-132.78M
2.66%20.02M
75.45%-2.29M
-546.94%-111.74M
78.57%-38.78M
---145.76M
--19.5M
Cash from discontinued investing activities
Investing cash flow
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
6.90%-138.4M
1.34%19.04M
63.12%-3.74M
-567.52%-113.26M
77.72%-40.44M
-3,145.63%-148.65M
1,521.48%18.79M
Financing cash flow
Cash flow from continuing financing activities
-102.99%-11K
22,781.94%101.37M
-98.95%206K
4,291.86%21.04M
92.74%690K
513.33%368K
3,927.27%443K
38,972.00%19.54M
-99.84%479K
-99.81%358K
Net common stock issuance
--0
--0
--0
--19.41M
--0
--0
--0
--19.41M
--0
--0
Proceeds from stock option exercised by employees
-102.99%-11K
22,781.94%101.37M
59.69%206K
240.29%1.63M
92.74%690K
513.33%368K
3,927.27%443K
158.00%129K
-48.99%479K
459.38%358K
Cash from discontinued financing activities
Financing cash flow
-102.99%-11K
22,781.94%101.37M
-98.95%206K
4,291.86%21.04M
92.74%690K
513.33%368K
3,927.27%443K
38,972.00%19.54M
-99.84%479K
-99.81%358K
Net cash flow
Beginning cash position
126.07%189.2M
-68.74%72.39M
45.71%71.55M
-83.13%49.11M
-2.50%55.83M
-11.73%83.69M
161.43%231.6M
-83.13%49.11M
645.46%291.06M
-53.13%57.26M
Current changes in cash
-284.78%-107.2M
178.98%116.82M
-99.54%834K
109.28%22.45M
292.79%15.72M
25.81%-27.86M
-2,475.22%-147.91M
190.13%182.49M
-196.01%-241.96M
-104.83%-8.15M
End cash Position
46.87%82M
126.07%189.2M
-68.74%72.39M
45.71%71.55M
45.71%71.55M
-2.50%55.83M
-11.73%83.69M
161.43%231.6M
-83.13%49.11M
-83.13%49.11M
Free cash flow
3.99%-24.91M
205.94%38.79M
-113.07%-26.36M
238.81%134.19M
82.19%-4.99M
8.31%-25.94M
-94.92%-36.61M
1,034.59%201.73M
-74.37%-96.67M
-28.13%-28.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.92%-24.27M213.51%39.83M-112.55%-25.52M249.07%139.8M85.30%-4.01M10.88%-24.49M-94.85%-35.09M1,068.98%203.4M-84.39%-93.79M-32.92%-27.3M
Net income from continuing operations -139.57%-14.03M312.25%55.03M452.05%23.5M92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M
Depreciation and amortization 12.35%937K24.66%910K72.64%934K49.92%2.84M39.92%736K61.63%834K57.67%730K38.72%541K69.65%1.9M44.51%526K
Change In working capital 79.44%-12.82M-63.14%-18.47M-124.95%-51.65M1,326.85%136.32M149.39%2.95M-1,025.92%-62.33M-652.24%-11.32M12,676.79%207.01M-224.79%-11.11M-55.82%-5.98M
-Change in receivables 495.86%5.07M2,635.61%69.84M-1,037.62%-71.64M---5.88M---853K---1.28M--2.55M---6.3M--0--0
-Change in prepaid assets 91.39%-1.27M-143.88%-2.87M-38.23%2.68M161.49%8.62M725.17%12.52M-55.36%-14.78M881.03%6.55M359.82%4.34M-108.26%-14.02M68.14%-2M
-Change in payables and accrued expense 114.60%865K51.04%-1.01M-129.00%-1.35M-28.63%5.03M3,240.64%8.39M-248.21%-5.92M-191.39%-2.07M767.48%4.64M117.09%7.05M-68.55%251K
-Change in other current assets 43.47%2.61M59.77%4.59M148.29%2.56M-87.14%426K146.70%1.03M-6.23%1.82M11.97%2.87M-619.71%-5.3M1,100.91%3.31M-239.07%-2.21M
-Change in other current liabilities 20.98%-3.13M70.72%-1.99M7.79%-1.8M-59.20%-11.86M141.76%841K-101.63%-3.96M-249.79%-6.79M-27.37%-1.95M---7.45M---2.01M
-Change in other working capital 55.60%-16.97M-503.22%-87.02M-91.54%17.9M--139.98M---18.97M---38.21M---14.43M--211.58M--------
Cash from discontinued investing activities
Operating cash flow 0.92%-24.27M213.51%39.83M-112.55%-25.52M249.07%139.8M85.30%-4.01M10.88%-24.49M-94.85%-35.09M1,068.98%203.4M-84.39%-93.79M-32.92%-27.3M
Investing cash flow
Cash flow from continuing investing activities -2,119.08%-82.93M78.47%-24.38M164.65%26.15M6.90%-138.4M1.34%19.04M63.12%-3.74M-567.52%-113.26M77.72%-40.44M-3,145.63%-148.65M1,521.48%18.79M
Net PPE purchase and sale 55.87%-639K31.27%-1.05M49.76%-838K-94.46%-5.61M-37.85%-976K-78.77%-1.45M-96.39%-1.52M-180.81%-1.67M36.97%-2.89M46.44%-708K
Net investment purchase and sale -3,494.93%-82.29M79.11%-23.34M169.59%26.99M8.91%-132.78M2.66%20.02M75.45%-2.29M-546.94%-111.74M78.57%-38.78M---145.76M--19.5M
Cash from discontinued investing activities
Investing cash flow -2,119.08%-82.93M78.47%-24.38M164.65%26.15M6.90%-138.4M1.34%19.04M63.12%-3.74M-567.52%-113.26M77.72%-40.44M-3,145.63%-148.65M1,521.48%18.79M
Financing cash flow
Cash flow from continuing financing activities -102.99%-11K22,781.94%101.37M-98.95%206K4,291.86%21.04M92.74%690K513.33%368K3,927.27%443K38,972.00%19.54M-99.84%479K-99.81%358K
Net common stock issuance --0--0--0--19.41M--0--0--0--19.41M--0--0
Proceeds from stock option exercised by employees -102.99%-11K22,781.94%101.37M59.69%206K240.29%1.63M92.74%690K513.33%368K3,927.27%443K158.00%129K-48.99%479K459.38%358K
Cash from discontinued financing activities
Financing cash flow -102.99%-11K22,781.94%101.37M-98.95%206K4,291.86%21.04M92.74%690K513.33%368K3,927.27%443K38,972.00%19.54M-99.84%479K-99.81%358K
Net cash flow
Beginning cash position 126.07%189.2M-68.74%72.39M45.71%71.55M-83.13%49.11M-2.50%55.83M-11.73%83.69M161.43%231.6M-83.13%49.11M645.46%291.06M-53.13%57.26M
Current changes in cash -284.78%-107.2M178.98%116.82M-99.54%834K109.28%22.45M292.79%15.72M25.81%-27.86M-2,475.22%-147.91M190.13%182.49M-196.01%-241.96M-104.83%-8.15M
End cash Position 46.87%82M126.07%189.2M-68.74%72.39M45.71%71.55M45.71%71.55M-2.50%55.83M-11.73%83.69M161.43%231.6M-83.13%49.11M-83.13%49.11M
Free cash flow 3.99%-24.91M205.94%38.79M-113.07%-26.36M238.81%134.19M82.19%-4.99M8.31%-25.94M-94.92%-36.61M1,034.59%201.73M-74.37%-96.67M-28.13%-28.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data